Alegori study: efficacy of a bevacizumab nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia (HHT). A randomized trial against placebo with dose selection
ANGIOGENESIS(2015)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined